Pingxiang Xu

899 total citations
43 papers, 716 citations indexed

About

Pingxiang Xu is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Pingxiang Xu has authored 43 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Biochemistry. Recurrent topics in Pingxiang Xu's work include Metabolomics and Mass Spectrometry Studies (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Pingxiang Xu is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Pingxiang Xu collaborates with scholars based in China, United States and Hong Kong. Pingxiang Xu's co-authors include Xiaorong Li, Ming Xue, Ming Xue, Wei Gu, Shanshan Guo, Yuming Zhao, Xuelin Zhou, Su Su, Yi Ma and Xiukun Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Pingxiang Xu

42 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingxiang Xu China 17 326 178 70 60 57 43 716
Peilin Yu China 19 376 1.2× 93 0.5× 71 1.0× 60 1.0× 76 1.3× 48 1.1k
Huan Shen China 18 316 1.0× 96 0.5× 72 1.0× 108 1.8× 93 1.6× 33 771
Donika Ivanova Bulgaria 15 321 1.0× 69 0.4× 86 1.2× 33 0.6× 95 1.7× 42 887
An Zhu China 20 379 1.2× 111 0.6× 122 1.7× 112 1.9× 79 1.4× 69 985
Afshin Mohammadi‐Bardbori Iran 17 299 0.9× 116 0.7× 38 0.5× 71 1.2× 69 1.2× 47 822
Da Yeon Lee South Korea 20 573 1.8× 108 0.6× 93 1.3× 71 1.2× 177 3.1× 41 1.1k
Makoto Ueda Japan 20 454 1.4× 92 0.5× 38 0.5× 51 0.8× 78 1.4× 74 901
Mohammad Algahtani Saudi Arabia 16 219 0.7× 84 0.5× 72 1.0× 35 0.6× 37 0.6× 48 668
Sayantani Chowdhury India 11 311 1.0× 58 0.3× 47 0.7× 106 1.8× 76 1.3× 12 950

Countries citing papers authored by Pingxiang Xu

Since Specialization
Citations

This map shows the geographic impact of Pingxiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingxiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingxiang Xu more than expected).

Fields of papers citing papers by Pingxiang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingxiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingxiang Xu. The network helps show where Pingxiang Xu may publish in the future.

Co-authorship network of co-authors of Pingxiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Pingxiang Xu. A scholar is included among the top collaborators of Pingxiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingxiang Xu. Pingxiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Qiang, Yi Wu, Yi Ma, et al.. (2024). Lysophospholipid acyltransferase‐mediated formation of saturated glycerophospholipids maintained cell membrane integrity for hypoxic adaptation. FEBS Journal. 291(14). 3191–3210. 6 indexed citations
3.
Sun, Zhihui, Tie Yan, Pingxiang Xu, et al.. (2023). Multi-omics approaches revealed the therapeutic mechanisms of Suo-Quan-Wan for treating overactive bladder in spontaneously hypertensive rats. Journal of Ethnopharmacology. 318(Pt B). 117066–117066. 3 indexed citations
4.
Liu, Yifan, et al.. (2023). The COVID-19 shock and the ownership of store Chain：Evidence from China's express delivery industry. Heliyon. 9(10). e20799–e20799. 1 indexed citations
5.
Bai, Lu, Yongchao Wang, Pingxiang Xu, et al.. (2022). Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for  Ischemic Stroke. International Journal of Nanomedicine. Volume 17. 3655–3670. 24 indexed citations
6.
Wu, Yi, Yi Ma, Jing Li, et al.. (2021). The bioinformatics and metabolomics research on anti-hypoxic molecular mechanisms of Salidroside via regulating the PTEN mediated PI3K/Akt/NF-κB signaling pathway. Chinese Journal of Natural Medicines. 19(6). 442–453. 7 indexed citations
7.
Wu, Yi, Yi Ma, Lu Bai, et al.. (2021). A UPLC-MS/MS method reveals the pharmacokinetics and metabolism characteristics of kaempferol in rats under hypoxia. Drug Metabolism and Pharmacokinetics. 43. 100440–100440. 16 indexed citations
8.
Bai, Lu, Xuelin Zhou, Pingxiang Xu, et al.. (2020). Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity. RSC Advances. 10(50). 30025–30034. 8 indexed citations
9.
Ma, Yi, Yi Wu, Jing Li, et al.. (2019). Anti-Hypoxic Molecular Mechanisms of Rhodiola crenulata Extract in Zebrafish as Revealed by Metabonomics. Frontiers in Pharmacology. 10. 1356–1356. 11 indexed citations
10.
Xu, Pingxiang, Liyun Wang, Yi Wu, et al.. (2019). Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness. Scientific Reports. 9(1). 2000–2000. 2 indexed citations
11.
12.
Xia, Binbin, Yali Li, Yatong Zhang, et al.. (2018). UHPLC-MS/MS method for determination of atorvastatin calcium in human plasma: Application to a pharmacokinetic study based on healthy volunteers with specific genotype. Journal of Pharmaceutical and Biomedical Analysis. 160. 428–435. 10 indexed citations
13.
Gong, Wenwen, Pingxiang Xu, Xiaorong Li, et al.. (2017). Effect of hypoxia on the pharmacokinetics and metabolism of zaleplon as a probe of CYP3A1/2 activity. RSC Advances. 7(41). 25414–25421. 4 indexed citations
14.
Bai, Lu, Ying Han, Pingxiang Xu, et al.. (2017). Plasma pharmacokinetics and brain distribution kinetics of lapachol in rats using LC-MS and microdialysis techniques. RSC Advances. 7(84). 53355–53361. 3 indexed citations
15.
Lü, Li, Xiaorong Li, Pingxiang Xu, Yan Zheng, & Xiaomin Wang. (2017). Tenuigenin down-regulates the release of nitric oxide, matrix metalloproteinase-9 and cytokines from lipopolysaccharide-stimulated microglia. Neuroscience Letters. 650. 82–88. 20 indexed citations
16.
Shao, Tao, Yi Qin, Pingxiang Xu, et al.. (2016). Pharmacokinetic comparison of roxithromycin under normoxic and hypoxic conditions in rats by UPLC/MS/MS. 32(11). 1601. 1 indexed citations
17.
Zhou, Tao, Mingming Wang, Can Cui, et al.. (2015). UPLC-HRMS based metabolomics reveals the sphingolipids with long fatty chains and olefinic bonds up-regulated in metabolic pathway for hypoxia preconditioning. Chemico-Biological Interactions. 242. 145–152. 15 indexed citations
18.
Cui, Can, Tao Zhou, Jing Li, et al.. (2015). Proteomic analysis of the mouse brain after repetitive exposure to hypoxia. Chemico-Biological Interactions. 236. 57–66. 16 indexed citations
19.
Lin, Xiukun, Huanli Xu, Xin Zhao, et al.. (2015). Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway. Drug Design Development and Therapy. 9. 2735–2735. 44 indexed citations
20.
Zhao, Yuming, Pingxiang Xu, Shengquan Hu, et al.. (2015). Tanshinone II A, a multiple target neuroprotectant, promotes caveolae-dependent neuronal differentiation. European Journal of Pharmacology. 765. 437–446. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peilin Yu Breakdown of academic impact, for papers by Huan Shen Breakdown of academic impact, for papers by Donika Ivanova Breakdown of academic impact, for papers by An Zhu Breakdown of academic impact, for papers by Afshin Mohammadi‐Bardbori Breakdown of academic impact, for papers by Da Yeon Lee Breakdown of academic impact, for papers by Makoto Ueda Breakdown of academic impact, for papers by Mohammad Algahtani Breakdown of academic impact, for papers by Sayantani Chowdhury
Rankless by CCL
2026